Bay City Capital News May 13, 2013 Bay City Capital Expands Team with the Addition of David Beier, JD
Portfolio News April 26, 2013 Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
Portfolio News February 27, 2013 Aciex Enters Into Collaborative Research Agreement with Portola to Develop Dual Syk/JAK Inhibitors for Ophthalmic Indication
Portfolio News February 1, 2013 Hyperion Therapeutics’ RAVICTI(TM) (glycerol phenylbutyrate) Liquid Receives FDA Approval for Treatment of Urea Cycle Disorders
Portfolio News January 24, 2013 Nevro Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment